Pennati M - Search Results

1

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, Valdagni R, Daidone MG, Zaffaroni N. Gandellini P, et al. Among authors: pennati m. Cancer Res. 2009 Mar 15;69(6):2287-95. doi: 10.1158/0008-5472.CAN-08-2894. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244118 Free article.

2

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells.

Paduano F, Villa R, Pennati M, Folini M, Binda M, Daidone MG, Zaffaroni N. Paduano F, et al. Among authors: pennati m. Mol Cancer Ther. 2006 Jan;5(1):179-86. doi: 10.1158/1535-7163.MCT-05-0132. Mol Cancer Ther. 2006. PMID: 16432177

3

miR-21: an oncomir on strike in prostate cancer.

Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, Valdagni R, Daidone MG, Zaffaroni N. Folini M, et al. Among authors: pennati m. Mol Cancer. 2010 Jan 21;9:12. doi: 10.1186/1476-4598-9-12. Mol Cancer. 2010. PMID: 20092645 Free PMC article.

4

MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs.

Pennati M, Folini M, Gandellini P, Zaffaroni N. Pennati M, et al. Curr Drug Targets. 2016;17(3):257-65. doi: 10.2174/1389450116666150316223341. Curr Drug Targets. 2016. PMID: 25777275 Review.

5

Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression.

Pennati M, Binda M, Colella G, Folini M, Citti L, Villa R, Daidone MG, Zaffaroni N. Pennati M, et al. J Invest Dermatol. 2003 Apr;120(4):648-54. doi: 10.1046/j.1523-1747.2003.12082.x. J Invest Dermatol. 2003. PMID: 12648230 Free article.

6

Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.

Pennati M, Binda M, Colella G, Zoppe' M, Folini M, Vignati S, Valentini A, Citti L, De Cesare M, Pratesi G, Giacca M, Daidone MG, Zaffaroni N. Pennati M, et al. Oncogene. 2004 Jan 15;23(2):386-94. doi: 10.1038/sj.onc.1207071. Oncogene. 2004. PMID: 14724567

7

Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.

Pennati M, Binda M, De Cesare M, Pratesi G, Folini M, Citti L, Daidone MG, Zunino F, Zaffaroni N. Pennati M, et al. Carcinogenesis. 2004 Jul;25(7):1129-36. doi: 10.1093/carcin/bgh107. Epub 2004 Feb 4. Carcinogenesis. 2004. PMID: 14764461

8

Survivin as a target for new anticancer interventions.

Zaffaroni N, Pennati M, Daidone MG. Zaffaroni N, et al. Among authors: pennati m. J Cell Mol Med. 2005 Apr-Jun;9(2):360-72. doi: 10.1111/j.1582-4934.2005.tb00361.x. J Cell Mol Med. 2005. PMID: 15963255 Free PMC article. Review.

9

Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.

Pennati M, Campbell AJ, Curto M, Binda M, Cheng Y, Wang LZ, Curtin N, Golding BT, Griffin RJ, Hardcastle IR, Henderson A, Zaffaroni N, Newell DR. Pennati M, et al. Mol Cancer Ther. 2005 Sep;4(9):1328-37. doi: 10.1158/1535-7163.MCT-05-0022. Mol Cancer Ther. 2005. PMID: 16170024

10

Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.

Zaffaroni N, Pennati M, Folini M. Zaffaroni N, et al. Among authors: pennati m. Methods Mol Biol. 2007;361:239-63. doi: 10.1385/1-59745-208-4:239. Methods Mol Biol. 2007. PMID: 17172716 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters